ConsumerFight.com
The Best Consumer Help Website in the World
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| Copyright ConsumerFight.com 2007, 2008 All rights Reserved. |
DRUG RISK RATING SYSTEM BENEFITS CONSUMERS
May 09, 2008 - Nearly half of all Americans take a prescription drug and one in six take three or
more. The number of serious side effects and deaths reported to the U.S. Food and Drug
Administration (FDA) has more than doubled over an eight-year period, according to recent
reports.* This, coupled with the continuous stream of news about adverse drug events, has
heightened physician and patient awareness about the need for better methods for
communicating risks and alerts to patients and in a format that is easily understood.
The iGuard Risk Rating system presented today at the International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting held
from May 3-17, 2008 in Toronto, Canada is helping to address this problem. The iGuard Risk
Rating system is a (patent pending) process for summarizing the likelihood and severity of
adverse events contained in each medication's prescribing information into a single rating.
The iGuard Risk Ratings, from lowest to highest, are as follows: 1) Green: Low Risk - Suitable
for widespread use; 2) Blue: General Risk - Use under normal care of a doctor; 3) Yellow:
Guarded - Be on the lookout for safety events; 4) Orange: Elevated Risk - Create a personal
risk reduction plan with your doctor; and 5) Red: High Risk - Requires careful consideration of
risk versus benefit.
Click on the red link above to continue the story.
Source: Red Orbit
May 09, 2008 - Nearly half of all Americans take a prescription drug and one in six take three or
more. The number of serious side effects and deaths reported to the U.S. Food and Drug
Administration (FDA) has more than doubled over an eight-year period, according to recent
reports.* This, coupled with the continuous stream of news about adverse drug events, has
heightened physician and patient awareness about the need for better methods for
communicating risks and alerts to patients and in a format that is easily understood.
The iGuard Risk Rating system presented today at the International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) 13th Annual International Meeting held
from May 3-17, 2008 in Toronto, Canada is helping to address this problem. The iGuard Risk
Rating system is a (patent pending) process for summarizing the likelihood and severity of
adverse events contained in each medication's prescribing information into a single rating.
The iGuard Risk Ratings, from lowest to highest, are as follows: 1) Green: Low Risk - Suitable
for widespread use; 2) Blue: General Risk - Use under normal care of a doctor; 3) Yellow:
Guarded - Be on the lookout for safety events; 4) Orange: Elevated Risk - Create a personal
risk reduction plan with your doctor; and 5) Red: High Risk - Requires careful consideration of
risk versus benefit.
Click on the red link above to continue the story.
Source: Red Orbit
